You are here

  • Home
  • Archive
  • Volume 29, Issue 2
  • Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients

Article metrics

Article menu
Download PDFPDF
Original Article
Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients

 

Online download statistics by month:

Online download statistics by month: January 2019 to December 2024

AbstractFullPdf
Jan 2019114142
Feb 20197104113
Mar 201942888
Apr 201916365
May 201993115
Jun 20198224
Jul 2019220106
Aug 201910411
Sep 201910522
Oct 20195845
Nov 20195311
Dec 201910611
Jan 20208900
Feb 20207031
Mar 20207812
Apr 202024410
May 20209601
Jun 202032431
Jul 202043725
Aug 202022800
Sep 202013232
Oct 20204210
Nov 20205011
Dec 20207700
Jan 20218700
Feb 20217401
Mar 20218221
Apr 20216132
May 20211602
Jun 2021100
Jul 2021111
Sep 2021200
Oct 20213400
Nov 20213100
Dec 20212810
Jan 20224330
Feb 20222822
Mar 20229711
Apr 20225500
May 20229112
Jun 20227010
Jul 20225340
Aug 20227720
Sep 20229330
Oct 20227863
Nov 20228215
Dec 20224101
Jan 20232901
Feb 20235710
Mar 20234212
Apr 20238320
May 20233220
Jun 20235911
Jul 20232300
Aug 20234921
Sep 20232921
Oct 20235810
Nov 20234600
Dec 20235011
Jan 20242310
Feb 20241100
Mar 20242021
Apr 20243511
May 20244811
Jun 20242700
Jul 20243121
Aug 20243974
Sep 20243400
Oct 20245712
Nov 20243821
Dec 2024800
Total6256177105